We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$7.2B
AUM Growth
+$563M
Cap. Flow
+$70.8M
Cap. Flow %
0.98%
Top 10 Hldgs %
62.14%
Holding
1,070
New
84
Increased
450
Reduced
405
Closed
54

Sector Composition

Rank Sector Weight
1 Technology 7.05%
2 Financials 3.36%
3 Communication Services 2.25%
4 Consumer Discretionary 1.98%
5 Healthcare 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KGC icon
376
Kinross Gold
KGC
$32.5B
$799K 0.01%
32,144
+565
+2% +$10.9K
IWP icon
377
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$792K 0.01%
5,559
+799
+17% +$113K
FTNT icon
378
Fortinet
FTNT
$117B
$790K 0.01%
9,399
-356
-4% -$31.8K
CCEP icon
379
Coca-Cola Europacific Partners
CCEP
$47.5B
$786K 0.01%
8,697
+196
+2% +$18.2K
TRI icon
380
Thomson Reuters
TRI
$44.5B
$783K 0.01%
4,962
+6
+0.1% +$1.12K
EQIX icon
381
Equinix
EQIX
$104B
$780K 0.01%
996
-565
-36% -$442K
AME icon
382
Ametek
AME
$58B
$775K 0.01%
4,122
+127
+3% +$23.4K
ROP icon
383
Roper Technologies
ROP
$39.6B
$764K 0.01%
1,532
-137
-8% -$73.1K
RY icon
384
Royal Bank of Canada
RY
$292B
$759K 0.01%
5,153
+75
+1% +$10.3K
IDXX icon
385
Idexx Laboratories
IDXX
$46.5B
$758K 0.01%
1,187
+50
+4% +$30.3K
ALNY icon
386
Alnylam Pharmaceuticals
ALNY
$28.9B
$757K 0.01%
1,661
+44
+3% +$17.9K
KRC icon
387
Kilroy Realty
KRC
$4.43B
$751K 0.01%
17,781
+448
+3% +$17.7K
NOBL icon
388
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$747K 0.01%
14,490
+6,436
+80% +$333K
DGX icon
389
Quest Diagnostics
DGX
$26.3B
$745K 0.01%
3,910
+78
+2% +$13.8K
FIX icon
390
Comfort Systems
FIX
$60.2B
$741K 0.01%
898
+19
+2% +$12.9K
VIV icon
391
Telefônica Brasil
VIV
$19.2B
$737K 0.01%
57,822
+2,924
+5% +$35.1K
GIS icon
392
General Mills
GIS
$19.4B
$734K 0.01%
14,559
-2,049
-12% -$103K
IRM icon
393
Iron Mountain
IRM
$36.5B
$730K 0.01%
7,160
+271
+4% +$26.1K
VXUS icon
394
Vanguard Total International Stock ETF
VXUS
$159B
$727K 0.01%
9,899
+181
+2% +$12.8K
DTD icon
395
WisdomTree US Total Dividend Fund
DTD
$1.69B
$726K 0.01%
8,640
BHP icon
396
BHP
BHP
$229B
$724K 0.01%
12,995
-342
-3% -$18.2K
AAXJ icon
397
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.76B
$722K 0.01%
7,914
QUAL icon
398
iShares MSCI USA Quality Factor ETF
QUAL
$47.8B
$721K 0.01%
3,706
-135
-4% -$25.3K
RACE icon
399
Ferrari
RACE
$72.1B
$720K 0.01%
1,484
-74
-5% -$35.5K
LTC
400
LTC Properties
LTC
$2.14B
$715K 0.01%
19,410
-737
-4% -$26.3K

Similar funds

Ballentine Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Ballentine Partners held 1,070 positions worth $7.2B, up 8.5% from $6.64B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Ballentine Partners's Q3 2025 filing shows 84 new, 450 increased, 405 reduced and 54 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund: 11,100 shares worth $987K. The largest sale was iShares Core S&P Total US Stock Market ETF, an estimated $4.49M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.8% a quarter earlier, followed by Financials and Communication Services.

  • Ballentine Partners's largest Q3 2025 buy was WisdomTree Trust WisdomTree US Quality Dividend Growth Fund: 11,100 shares worth $987K.
  • Ballentine Partners added most to Vanguard Morningstar Total Stock Market ETF in Q3 2025, an estimated $33.8M increase.
  • Ballentine Partners's biggest Q3 2025 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $4.49M.
  • Ballentine Partners fully exited Vanguard Intermediate-Term Treasury ETF in Q3 2025, selling an estimated $2.35M.
  • Ballentine Partners's ten largest holdings make up 62% of its $7.2B portfolio in Q3 2025.
  • Ballentine Partners opened 84 new positions and closed 54 in Q3 2025.
  • Ballentine Partners's portfolio value rose 8.5% quarter-over-quarter to $7.2B.

Based on Ballentine Partners's 13F filing for Q3 2025, filed 3 Nov 2025.